论文部分内容阅读
目的:探究丹参川芎嗪注射液治疗脑梗死患者的临床疗效。方法:选择我院收治的112例脑梗死患者随机分成对照组与观察组各56例,对照组给予常规治疗,观察组在常规治疗的基础上给予丹参川芎嗪注射液,连续用药10天。观察治疗前、后神经功能受损程度评分(NIHSS)和Barthel指数情况、监测临床疗效及治疗期间所发生的不良反应情况。结果:治疗后,对照组治疗有效率为85.71%,观察组治疗有效率为96.40%,观察组治疗效率明显较对照组高,数据差异具有统计学意义(P<0.05)。两组患者在治疗中无明显不良反应。结论:丹参川芎嗪注射液治疗急性脑梗死比常规治疗方法临床具有更好疗效,值得临床推广。
Objective: To investigate the clinical effect of ligustrazine injection on patients with cerebral infarction. Methods: A total of 112 patients with cerebral infarction admitted to our hospital were randomly divided into control group and observation group with 56 cases in each group. The control group was given routine treatment. The observation group was given Salviae Miltiorrhizae ligustrazine injection on the basis of routine treatment for 10 consecutive days. The scores of NIHSS and Barthel index before and after treatment were observed, and the clinical efficacy and the adverse reactions during the treatment were monitored. Results: After treatment, the effective rate was 85.71% in the control group and 96.40% in the observation group. The treatment efficiency in the observation group was significantly higher than that in the control group (P <0.05). Two groups of patients in the treatment without significant adverse reactions. Conclusion: Salviae miltiorrhizae injection of Ligustrazine injection in the treatment of acute cerebral infarction has better curative effect than the conventional treatment, which is worthy of clinical promotion.